Captrust Financial Advisors Cerus Corp Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.25 - $2.35 $12,658 - $23,798	10,127 New	10,127 $21,000
Q2 2022 Aug 23, 2022	SELL	$4.41 - $5.69 $2,399 - $3,095	-544 Reduced 48.75%	572 $3,000
Q2 2022 Aug 16, 2022	BUY	$4.41 - $5.69 $2,399 - $3,095	544 Added 95.1%	1,116 $6,000
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $577 - $838	120 Added 26.55%	572 $3,000
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $895 - $1,189	-150 Reduced 24.92%	452 $3,000
Q3 2021 Nov 16, 2021	BUY	$4.79 - $6.68 $684 - $955	143 Added 31.15%	602 $4,000
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $2,607 - $3,612	459 New	459 $3,000

157

150M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $329M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.